Get comprehensive lung cancer genetic testing with our Lung Cancer Mutation Panel Test for only $526 in USA. Advanced molecular analysis for EGFR and ALK mutations helps guide targeted therapy decisions. Available in New York
Get comprehensive FISH NTRK3 Gene Rearrangement Assay testing for $176 USD in USA. Advanced cancer genetic testing available in New York FISH NTRK3 Gene Rearrangement Assay Test Original price was: $196.Current price is: $176.
Sale!

Lung Cancer Mutation Panel Test

Original price was: $750.Current price is: $526.

-30%

The Lung Cancer Mutation Panel Test is a comprehensive molecular diagnostic tool that analyzes specific genetic mutations in lung cancer tumors. This advanced test detects EGFR and ALK gene alterations that drive cancer growth, providing crucial information for targeted therapy selection. Patients with non-small cell lung cancer benefit from this testing to identify effective treatment options. The test requires formalin-fixed paraffin-embedded tissue samples and provides results within one week. At only $526 USD, this test offers significant savings from the regular $750 price. Early genetic profiling can lead to more personalized and effective cancer treatment strategies.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Lung Cancer Mutation Panel Test: Comprehensive Genetic Analysis for Personalized Cancer Treatment

Understanding Lung Cancer Mutation Testing

The Lung Cancer Mutation Panel Test represents a breakthrough in precision oncology, offering detailed genetic analysis of lung cancer tumors to guide targeted treatment decisions. This comprehensive molecular diagnostic test examines specific genetic alterations that drive cancer growth, enabling oncologists to select the most effective therapies based on your tumor’s unique genetic profile.

What Does the Lung Cancer Mutation Panel Test Measure?

This advanced genetic panel specifically analyzes two critical biomarkers in lung cancer:

  • EGFR Mutations: Epidermal Growth Factor Receptor gene alterations that respond to targeted therapy drugs
  • ALK Rearrangements: Anaplastic Lymphoma Kinase gene fusions that indicate sensitivity to ALK inhibitors

The test utilizes sophisticated laboratory techniques including Fluorescence In Situ Hybridization (FISH) and Polymerase Chain Reaction (PCR) to detect these genetic abnormalities with high accuracy and reliability.

Who Should Consider This Genetic Testing?

Clinical Indications and Symptoms

This test is particularly valuable for patients experiencing:

  • Newly diagnosed non-small cell lung cancer (NSCLC)
  • Advanced or metastatic lung cancer requiring treatment planning
  • Progressive disease despite conventional chemotherapy
  • Family history of lung cancer or genetic predisposition
  • Need for personalized treatment strategy based on tumor genetics

Benefits of Comprehensive Genetic Testing

Undergoing the Lung Cancer Mutation Panel Test provides numerous advantages:

  • Personalized Treatment Selection: Identify which targeted therapies will be most effective for your specific cancer type
  • Improved Treatment Outcomes: Targeted therapies often show better response rates and fewer side effects
  • Informed Clinical Decisions: Provide your oncologist with critical genetic information for treatment planning
  • Early Intervention Opportunities: Detect actionable mutations before disease progression
  • Cost-Effective Care: Avoid ineffective treatments and associated side effects

Understanding Your Test Results

Interpreting Genetic Findings

Your test results will provide detailed information about:

  • EGFR Mutation Status: Positive results indicate potential response to EGFR tyrosine kinase inhibitors
  • ALK Rearrangement Status: Positive findings suggest sensitivity to ALK inhibitor medications
  • Negative Results: No detectable mutations, indicating alternative treatment approaches may be needed

Your oncologist will review these results in the context of your overall health status, cancer stage, and treatment history to develop the most appropriate therapeutic strategy.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $526
Regular Price $750

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services for patients nationwide.

Sample Requirements and Processing

The Lung Cancer Mutation Panel Test requires:

  • Formalin-fixed paraffin-embedded tissue block OR three 4-micron sections on Poly-L-Lysine coated slides
  • Shipment at room temperature
  • Completed Genomics Clinical Information Requisition Form (Form 20)

Turnaround Time: Samples received by Tuesday at 11:00 AM will have results available by the following Monday.

Take Control of Your Cancer Treatment Journey

Don’t leave your treatment decisions to chance. The Lung Cancer Mutation Panel Test provides the genetic intelligence needed to fight lung cancer with precision and purpose. Our experienced genetic counselors and oncology specialists are ready to guide you through the testing process and help interpret your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Lung Cancer Mutation Panel Test and take the first step toward personalized cancer care.

SKU: 1599 Category:

Related products